Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 1682-1689, May 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xue, W.
Right arrow Articles by Petty, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xue, W.
Right arrow Articles by Petty, H. R.

Urokinase-Type Plasminogen Activator Receptors Associate with ß1 and ß3 Integrins of Fibrosarcoma Cells: Dependence on Extracellular Matrix Components1

Wei Xue, Ikuko Mizukami, Robert F. Todd, III and Howard R. Petty2

Department of Biological Sciences, Wayne State University, Detroit, Michigan 48202 [W. X., H. R. P.], and Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109 [I. M., R. F. T.]

We have shown previously that the urokinase-type plasminogen activator receptor (uPAR) physically associates with ß2 integrins on human leukocyte membranes. We now report that uPAR associates with certain members of the ß1 and ß3 integrin families expressed by a nonhematopoietic fibrosarcoma cell line (HT1080) when adherent to certain extracellular matrix molecules. Flow cytometry studies indicated that HT1080 cells expressed uPAR and ß1 and ß3 integrins. Double staining immunofluorescence was used to label uPAR and ß1 and ß3 integrins. The staining patterns of uPAR and ß1 integrins were strikingly similar when attached to fibronectin, laminin, or vitronectin but not polylysine-coated substrates. Resonance energy transfer (RET) between uPAR and ß1 integrins was observed, especially at focal adhesion plaques; this indicates that these molecules are within about 7 nm of each other on these cell membranes. uPAR and ß3 integrin coclustering and RET were also observed on tumor cells adherent to vitronectin but not to fibronectin, laminin, or polylysine-coated surfaces. Because N-acetyl-D-glucosamine was found previously to inhibit ß2 integrin-uPAR association, we tested the effect of saccharides on the ß1-uPAR and ß3-uPAR colocalization and RET. Colocalization and RET between uPAR and ß1 or ß3 integrins were effectively inhibited by N-acetyl-D-glucosamine on extracellular matrix-coated surfaces. To better define which members of ß1 and ß3 integrin families associate with uPAR, we studied the association of several {alpha} subunits with uPAR on tumor cells. We found that: (a) {alpha}5 colocalizes with uPAR on cells attached to fibronectin-coated surfaces; (b) {alpha}5 and {alpha}v colocalize with uPAR on cells adherent to vitronectin; and (c) {alpha}3 and {alpha}6 associate with uPAR on cells attached to laminin. In further support of physical associations between integrins and uPAR on tumor cells, uPAR was found to coimmunoprecipitate with ß1 integrins in Brij-58 lysates of HT1080 cells (as detected by anti-uPAR Western blotting of material isolated from an anti-ß1 integrin immunoaffinity column). Thus, uPAR may laterally associate with integrins of tumor cells when attached to specific extracellular matrix elements to enable directional proteolysis for tumor cell migration and invasion.

1 This work was supported by NIH Grant AI/CA27409 and the Research Stimulation Fund of Wayne State University (to H. R. P.) and NIH Grants CA39064 and CA42246 (to R. F. T.).

2 To whom requests for reprints should be addressed. Phone: (313) 577-2896; Fax: (313) 577-9008.

Received 9/16/96. Accepted 3/ 1/97.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
C.-H. Tang, M. L. Hill, A. N. Brumwell, H. A. Chapman, and Y. Wei
Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with {beta}1 integrins
J. Cell Sci., November 15, 2008; 121(22): 3747 - 3756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-L. Tang, A. Vararattanavech, and S.-M. Tan
Urokinase-type Plasminogen Activator Receptor Induces Conformational Changes in the Integrin {alpha}M{beta}2 Headpiece and Reorientation of Its Transmembrane Domains
J. Biol. Chem., September 12, 2008; 283(37): 25392 - 25403.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
H. W. Smith, P. Marra, and C. J. Marshall
uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180
J. Cell Biol., August 25, 2008; 182(4): 777 - 790.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hillig, L. H. Engelholm, S. Ingvarsen, D. H. Madsen, H. Gardsvoll, J. K. Larsen, M. Ploug, K. Dano, L. Kjoller, and N. Behrendt
A Composite Role of Vitronectin and Urokinase in the Modulation of Cell Morphology upon Expression of the Urokinase Receptor
J. Biol. Chem., May 30, 2008; 283(22): 15217 - 15223.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. J. Garrigues, Y. E. Rubinchikova, C. M. DiPersio, and T. M. Rose
Integrin {alpha}V 3 Binds to the RGD Motif of Glycoprotein B of Kaposi's Sarcoma-Associated Herpesvirus and Functions as an RGD-Dependent Entry Receptor
J. Virol., February 1, 2008; 82(3): 1570 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. He, X.-d. Liu, Z.-y. Chen, J. Zhu, Y. Xiong, K. Li, J.-h. Dong, and X. Li
Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis
Clin. Cancer Res., June 1, 2007; 13(11): 3115 - 3124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wei, C.-H. Tang, Y. Kim, L. Robillard, F. Zhang, M. C. Kugler, and H. A. Chapman
Urokinase Receptors Are Required for {alpha}5beta1 Integrin-mediated Signaling in Tumor Cells
J. Biol. Chem., February 9, 2007; 282(6): 3929 - 3939.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. S. Gondi, N. Kandhukuri, S. Kondraganti, M. Gujrati, W. C. Olivero, D. H. Dinh, and J. S. Rao
RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells
Mol. Cancer Ther., December 1, 2006; 5(12): 3197 - 3208.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Stefanidakis and E. Koivunen
Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression
Blood, September 1, 2006; 108(5): 1441 - 1450.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Chaurasia, J. A. Aguirre-Ghiso, O. D. Liang, H. Gardsvoll, M. Ploug, and L. Ossowski
A Region in Urokinase Plasminogen Receptor Domain III Controlling a Functional Association with {alpha}5beta1 Integrin and Tumor Growth
J. Biol. Chem., May 26, 2006; 281(21): 14852 - 14863.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ghosh, J. J. Johnson, R. Sen, S. Mukhopadhyay, Y. Liu, F. Zhang, Y. Wei, H. A. Chapman, and M. S. Stack
Functional Relevance of Urinary-type Plasminogen Activator Receptor-{alpha}3beta1 Integrin Association in Proteinase Regulatory Pathways
J. Biol. Chem., May 12, 2006; 281(19): 13021 - 13029.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S.-H. Kwak, S. Mitra, K. Bdeir, D. Strassheim, J. S. Park, J. Y. Kim, S. Idell, D. Cines, and E. Abraham
The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins
J. Leukoc. Biol., October 1, 2005; 78(4): 937 - 945.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. W. Bauer, W. Liu, F. Fan, E. R. Camp, A. Yang, R. J. Somcio, C. D. Bucana, J. Callahan, G. C. Parry, D. B. Evans, et al.
Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met- and Insulin-like Growth Factor-I Receptor-Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice
Cancer Res., September 1, 2005; 65(17): 7775 - 7781.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Degryse, M. Resnati, R.-P. Czekay, D. J. Loskutoff, and F. Blasi
Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity: GENERATION OF A NEW INTEGRIN INHIBITOR
J. Biol. Chem., July 1, 2005; 280(26): 24792 - 24803.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Y. Wei, R.-P. Czekay, L. Robillard, M. C. Kugler, F. Zhang, K. K. Kim, J.-p. Xiong, M. J. Humphries, and H. A. Chapman
Regulation of {alpha}5{beta}1 integrin conformation and function by urokinase receptor binding
J. Cell Biol., January 31, 2005; 168(3): 501 - 511.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. M. Beauvais, B. J. Burbach, and A. C. Rapraeger
The syndecan-1 ectodomain regulates {alpha}v{beta}3 integrin activity in human mammary carcinoma cells
J. Cell Biol., October 11, 2004; 167(1): 171 - 181.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. M. Bernstein, R. S. Greenberg, L. Taliana, and S. K. Masur
Urokinase Anchors uPAR to the Actin Cytoskeleton
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2967 - 2977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Mayasundari, N. A. Whittemore, E. H. Serpersu, and C. B. Peterson
The Solution Structure of the N-terminal Domain of Human Vitronectin: PROXIMAL SITES THAT REGULATE FIBRINOLYSIS AND CELL MIGRATION
J. Biol. Chem., July 9, 2004; 279(28): 29359 - 29366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bjorklund, P. Heikkila, and E. Koivunen
Peptide Inhibition of Catalytic and Noncatalytic Activities of Matrix Metalloproteinase-9 Blocks Tumor Cell Migration and Invasion
J. Biol. Chem., July 9, 2004; 279(28): 29589 - 29597.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A Noel, C Maillard, N Rocks, M Jost, V Chabottaux, N E Sounni, E Maquoi, D Cataldo, and J M Foidart
Membrane associated proteases and their inhibitors in tumour angiogenesis
J. Clin. Pathol., June 1, 2004; 57(6): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-B. Huang, A. L. Kindzelskii, A. J. Clark, and H. R. Petty
Identification of Channels Promoting Calcium Spikes and Waves in HT1080 Tumor Cells: Their Apparent Roles in Cell Motility and Invasion
Cancer Res., April 1, 2004; 64(7): 2482 - 2489.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. M. Kanse, T. Chavakis, N. Al-Fakhri, K. Hersemeyer, D. Monard, and K. T. Preissner
Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1
J. Cell Sci., January 22, 2004; 117(3): 477 - 485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Jo, K. S. Thomas, L. Wu, and S. L. Gonias
Soluble Urokinase-type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-independent Effects on Cell Signaling
J. Biol. Chem., November 21, 2003; 278(47): 46692 - 46698.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Bdeir, A. Kuo, B. S. Sachais, A. H. Rux, Y. Bdeir, A. Mazar, A. A.-R. Higazi, and D. B. Cines
The kringle stabilizes urokinase binding to the urokinase receptor
Blood, November 15, 2003; 102(10): 3600 - 3608.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Tarui, N. Andronicos, R.-P. Czekay, A. P. Mazar, K. Bdeir, G. C. Parry, A. Kuo, D. J. Loskutoff, D. B. Cines, and Y. Takada
Critical Role of Integrin {alpha}5{beta}1 in Urokinase (uPA)/Urokinase Receptor (uPAR, CD87) Signaling
J. Biol. Chem., August 8, 2003; 278(32): 29863 - 29872.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Vehvilainen, M. Hyytiainen, and J. Keski-Oja
Latent Transforming Growth Factor-{beta}-binding Protein 2 Is an Adhesion Protein for Melanoma Cells
J. Biol. Chem., June 27, 2003; 278(27): 24705 - 24713.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, P. Carmeliet, and A. A. Eddy
Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1234 - 1253.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kobayashi, M. Suzuki, Y. Tanaka, N. Kanayama, and T. Terao
A Kunitz-type Protease Inhibitor, Bikunin, Inhibits Ovarian Cancer Cell Invasion by Blocking the Calcium-dependent Transforming Growth Factor-beta 1 Signaling Cascade
J. Biol. Chem., February 28, 2003; 278(10): 7790 - 7799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Jo, K. S. Thomas, D. M. O'Donnell, and S. L. Gonias
Epidermal Growth Factor Receptor-dependent and -independent Cell-signaling Pathways Originating from the Urokinase Receptor
J. Biol. Chem., January 10, 2003; 278(3): 1642 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Xia, G. Borland, J. Huang, I. F. Mizukami, H. R. Petty, R. F. Todd III, and G. D. Ross
Function of the Lectin Domain of Mac-1/Complement Receptor Type 3 (CD11b/CD18) in Regulating Neutrophil Adhesion
J. Immunol., December 1, 2002; 169(11): 6417 - 6426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Montuori, M. V. Carriero, S. Salzano, G. Rossi, and P. Ragno
The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions
J. Biol. Chem., November 27, 2002; 277(49): 46932 - 46939.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Leksa, S. Godar, M. Cebecauer, I. Hilgert, J. Breuss, U. H. Weidle, V. Horejsi, B. R. Binder, and H. Stockinger
The N Terminus of Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor in Regulation of Fibrinolysis and Cell Migration
J. Biol. Chem., October 18, 2002; 277(43): 40575 - 40582.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Besta, S. Massberg, K. Brand, E. Muller, S. Page, S. Gruner, M. Lorenz, K. Sadoul, W. Kolanus, E. Lengyel, et al.
Role of {beta}3-endonexin in the regulation of NF-{kappa}B-dependent expression of urokinase-type plasminogen activator receptor
J. Cell Sci., October 15, 2002; 115(20): 3879 - 3888.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. V. Artym, A. L. Kindzelskii, W.-T. Chen, and H. R. Petty
Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on {beta}1 integrins and the cytoskeleton
Carcinogenesis, October 1, 2002; 23(10): 1593 - 1602.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
V. V. Artym and H. R. Petty
Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and {beta}1-Integrins on the Plasma Membrane of Melanoma Cells: Effects of Cell Adherence and Channel Blockers
J. Gen. Physiol., June 10, 2002; 120(1): 29 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Sturge, J. Hamelin, and G. E. Jones
N-WASP activation by a {beta}1-integrin-dependent mechanism supports PI3K-independent chemotaxis stimulated by urokinase-type plasminogen activator
J. Cell Sci., February 15, 2002; 115(4): 699 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Chen, C. Baskerville, Q. Han, Z. K. Pan, and S. Huang
alpha v Integrin, p38 Mitogen-activated Protein Kinase, and Urokinase Plasminogen Activator Are Functionally Linked in Invasive Breast Cancer Cells
J. Biol. Chem., December 14, 2001; 276(51): 47901 - 47905.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Gyetko, S. Sud, J. Sonstein, T. Polak, A. Sud, and J. L. Curtis
Cutting Edge: Antigen-Driven Lymphocyte Recruitment to the Lung Is Diminished in the Absence of Urokinase-Type Plasminogen Activator (uPA) Receptor, but Is Independent of uPA
J. Immunol., November 15, 2001; 167(10): 5539 - 5542.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Wei, J. A. Eble, Z. Wang, J. A. Kreidberg, and H. A. Chapman
Urokinase Receptors Promote beta 1 Integrin Function through Interactions with Integrin alpha 3beta 1
Mol. Biol. Cell, October 1, 2001; 12(10): 2975 - 2986.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. van der Pluijm, B. Sijmons, H. Vloedgraven, C. van der Bent, J.-W. Drijfhout, J. Verheijen, P. Quax, M. Karperien, S. Papapoulos, and C. Lowik
Urokinase-Receptor/Integrin Complexes Are Functionally Involved in Adhesion and Progression of Human Breast Cancer in Vivo
Am. J. Pathol., September 1, 2001; 159(3): 971 - 982.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R.-P. Czekay, T. A. Kuemmel, R. A. Orlando, and M. G. Farquhar
Direct Binding of Occupied Urokinase Receptor (uPAR) to LDL Receptor-related Protein Is Required for Endocytosis of uPAR and Regulation of Cell Surface Urokinase Activity
Mol. Biol. Cell, May 1, 2001; 12(5): 1467 - 1479.
[Abstract] [Full Text]


Home page
FASEB J.Home page
K. HORINO, A. L. KINDEZELSKII, V. M. ELNER, B. A. HUGHES, and H. R. PETTY
Tumor cell invasion of model 3-dimensional matrices: demonstration of migratory pathways, collagen disruption, and intercellular cooperation
FASEB J, April 1, 2001; 15(6): 932 - 939.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
L. Kjoller and A. Hall
Rac Mediates Cytoskeletal Rearrangements and Increased Cell Motility Induced by Urokinase-Type Plasminogen Activator Receptor Binding to Vitronectin
J. Cell Biol., March 19, 2001; 152(6): 1145 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Hapke, M. Gawaz, K. Dehne, J. Köhler, J. F. Marshall, H. Graeff, M. Schmitt, U. Reuning, and E. Lengyel
{beta}3A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through a PEA3/ets Transcriptional Silencing Element in the u-PAR Promoter
Mol. Cell. Biol., March 15, 2001; 21(6): 2118 - 2132.
[Abstract] [Full Text]


Home page
CROBMHome page
B. Steffensen, L. Hakkinen, and H. Larjava
Proteolytic Events of Wound-Healing -- Coordinated Interactions Among Matrix Metalloproteinases (MMPs), Integrins, and Extracellular Matrix Molecules
Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(5): 373 - 398.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Mazumdar, L. Adam, D. Boyd, and R. Kumar
Heregulin Regulation of Urokinase Plasminogen Activator and its Receptor: Human Breast Epithelial Cell Invasion
Cancer Res., January 1, 2001; 61(1): 400 - 405.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
R. G. Sitrin, P. M. Pan, H. A. Harper, R. F. Todd III, D. M. Harsh, and R. A. Blackwood
Clustering of Urokinase Receptors (uPAR; CD87) Induces Proinflammatory Signaling in Human Polymorphonuclear Neutrophils
J. Immunol., September 15, 2000; 165(6): 3341 - 3349.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. W.Y. Wong, G. Wiedle, C. Ballestrem, B. Wehrle-Haller, S. Etteldorf, M. Bruckner, B. Engelhardt, R. H. Gisler, and B. A. Imhof
PECAM-1/CD31 Trans-homophilic Binding at the Intercellular Junctions Is Independent of Its Cytoplasmic Domain; Evidence for Heterophilic Interaction with Integrin alpha vbeta 3 in Cis
Mol. Biol. Cell, September 1, 2000; 11(9): 3109 - 3121.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. I. Simon, Y. Wei, L. Zhang, N. K. Rao, H. Xu, Z. Chen, Q. Liu, S. Rosenberg, and H. A. Chapman
Identification of a Urokinase Receptor-Integrin Interaction Site. PROMISCUOUS REGULATOR OF INTEGRIN FUNCTION
J. Biol. Chem., March 31, 2000; 275(14): 10228 - 10234.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Kindzelskii, Z.-y. Yang, G. J. Nabel, R. F. Todd III, and H. R. Petty
Ebola Virus Secretory Glycoprotein (sGP) Diminishes Fc{gamma}RIIIB-to-CR3 Proximity on Neutrophils
J. Immunol., January 15, 2000; 164(2): 953 - 958.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. A. A. Ghiso, K. Kovalski, and L. Ossowski
Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling
J. Cell Biol., October 4, 1999; 147(1): 89 - 104.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. V. Carriero, S. D. Vecchio, M. Capozzoli, P. Franco, L. Fontana, A. Zannetti, G. Botti, G. D'Aiuto, M. Salvatore, and M. P. Stoppelli
Urokinase Receptor Interacts with {{alpha}}v{{beta}}5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer
Cancer Res., October 1, 1999; 59(20): 5307 - 5314.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Degryse, M. Resnati, S. A. Rabbani, A. Villa, F. Fazioli, and F. Blasi
Src-Dependence and Pertussis-Toxin Sensitivity of Urokinase Receptor-Dependent Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells
Blood, July 15, 1999; 94(2): 649 - 662.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. H.D. Nguyen, A. D. Catling, D. J. Webb, M. Sankovic, L. A. Walker, A. V. Somlyo, M. J. Weber, and S. L. Gonias
Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-Type Plasminogen Activator-Stimulated Cells in an Integrin-Selective Manner
J. Cell Biol., July 12, 1999; 146(1): 149 - 164.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Mira, S. Mañes, R. A. Lacalle, G. Márquez, and C. Martínez-A
Insulin-Like Growth Factor I-Triggered Cell Migration and Invasion Are Mediated by Matrix Metalloproteinase-9
Endocrinology, April 1, 1999; 140(4): 1657 - 1664.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola
The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1
J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H Gardner, A Broberg, A Pozzi, M Laato, and J Heino
Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis
J. Cell Sci., January 2, 1999; 112(3): 263 - 272.
[Abstract] [PDF]


Home page
GutHome page
S Suzuki, Y Hayashi, Y Wang, T Nakamura, Y Morita, K Kawasaki, K Ohta, N Aoyama, S R Kim, H Itoh, et al.
Urokinase type plasminogen activator receptor expression in colorectal neoplasms
Gut, December 1, 1998; 43(6): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. Weerasinghe, K. P. McHugh, F. P. Ross, E. J. Brown, R. H. Gisler, and B. A. Imhof
A Role for the {alpha}v{beta}3 Integrin in the Transmigration of Monocytes
J. Cell Biol., July 27, 1998; 142(2): 595 - 607.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. J. Shattil, H. Kashiwagi, and N. Pampori
Integrin Signaling: The Platelet Paradigm
Blood, April 15, 1998; 91(8): 2645 - 2657.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Koshelnick, M. Ehart, P. Hufnagl, P. C. Heinrich, and B. R. Binder
Urokinase Receptor Is Associated with the Components of the JAK1/STAT1 Signaling Pathway and Leads to Activation of This Pathway upon Receptor Clustering in the Human Kidney Epithelial Tumor Cell Line TCL-598
J. Biol. Chem., November 7, 1997; 272(45): 28563 - 28567.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ghosh, R. Brown, J. C. R. Jones, S. M. Ellerbroek, and M. S. Stack
Urinary-type Plasminogen Activator (uPA) Expression and uPA Receptor Localization Are Regulated by alpha 3beta 1 Integrin in Oral Keratinocytes
J. Biol. Chem., July 28, 2000; 275(31): 23869 - 23876.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Tarui, A. P. Mazar, D. B. Cines, and Y. Takada
Urokinase-type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell Interaction
J. Biol. Chem., February 2, 2001; 276(6): 3983 - 3990.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hapke, H. Kessler, N. A. de Prada, A. Benge, M. Schmitt, E. Lengyel, and U. Reuning
Integrin alpha vbeta 3/Vitronectin Interaction Affects Expression of the Urokinase System in Human Ovarian Cancer Cells
J. Biol. Chem., July 6, 2001; 276(28): 26340 - 26348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Mukhina, V. Stepanova, D. Traktouev, A. Poliakov, R. Beabealashvilly, Y. Gursky, M. Minashkin, A. Shevelev, and V. Tkachuk
The Chemotactic Action of Urokinase on Smooth Muscle Cells Is Dependent on Its Kringle Domain. CHARACTERIZATION OF INTERACTIONS AND CONTRIBUTION TO CHEMOTAXIS
J. Biol. Chem., May 26, 2000; 275(22): 16450 - 16458.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. H. D. Nguyen, D. J. Webb, A. D. Catling, Q. Song, A. Dhakephalkar, M. J. Weber, K. S. Ravichandran, and S. L. Gonias
Urokinase-type Plasminogen Activator Stimulates the Ras/Extracellular Signal-regulated Kinase (ERK) Signaling Pathway and MCF-7 Cell Migration by a Mechanism That Requires Focal Adhesion Kinase, Src, and Shc. RAPID DISSOCIATION OF GRB2/SOS-SHC COMPLEX IS ASSOCIATED WITH THE TRANSIENT PHOSPHORYLATION OF ERK IN UROKINASE-TREATED CELLS
J. Biol. Chem., June 16, 2000; 275(25): 19382 - 19388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Woods and J. R. Couchman
Integrin Modulation by Lateral Association
J. Biol. Chem., August 4, 2000; 275(32): 24233 - 24236.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.